Zobrazeno 1 - 10
of 114
pro vyhledávání: '"S S, Legha"'
Autor:
Jeffrey E. Lee, Wen-Jen Hwu, Rene Gonzalez, Agop Y. Bedikian, Omar Eton, Patrick Hwu, Ping Liu, Carl Plager, Kevin B. Kim, Marcella M. Johnson, Antonio C. Buzaid, Angela M. Frost, Robert S. Benjamin, Jeffrey E. Gershenwald, Victor G. Prieto, Paul F. Mansfield, Nicholas E. Papadopoulos, Clay M. Anderson, Merrick I. Ross, Gladys Alvarado, S. S. Legha
Publikováno v:
Melanoma Research. 19:42-49
The objective of this study was to compare the clinical benefit of biochemotherapy and interferon-alpha-2b (IFN) as adjuvant therapy. Biochemotherapy has higher response rates than other regimens in patients with metastatic melanoma. We conducted a r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae5d7feae1e9c0a04d2b70f1038d511
https://doi.org/10.1097/cmr.0b013e328314b84a
https://doi.org/10.1097/cmr.0b013e328314b84a
Autor:
Omar Eton, Antonio Buzaid, R N Mary Jo East, Michael G. Rosenblum, S. S. Legha, Wehei Zhang, Nicholas Papadopoulos, Agop Bedikian, Robert S. Benjamin
Publikováno v:
Cancer. 95:127-134
BACKGROUND Interleukin-2 (IL-2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c2a9006a1b7227b40d2d45891836f1
https://doi.org/10.1002/cncr.10631
https://doi.org/10.1002/cncr.10631
Autor:
Diane Bodurka-Bevers, Claire F. Verschraegen, W. Supakarapongkul, Lawrence B. Levy, Edward N. Atkinson, Mongkol Benjapibal, Andrzej P. Kudelka, John J. Kavanagh, S. S. Legha, Merrick I. Ross
Publikováno v:
International Journal of Gynecological Cancer. 11:359-364
The purpose of this study was to review the clinical course of patients diagnosed with vulvar melanoma. Charts of patients diagnosed between 1970 and 1997 were reviewed for demographics, lesion characteristics, disease duration and extent, and treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44153d48e47cf78d49eb06dfc1b74bba
https://doi.org/10.1046/j.1525-1438.2001.01043.x
https://doi.org/10.1046/j.1525-1438.2001.01043.x
Autor:
M R N Teresa Smith, Julie A. Ellerhorst, Antonio C. Buzaid, Agop Y. Bedikian, S. S. Legha, L R N Janelle Hibberts, Nicholas E. Papadopoulos, Omar Eton, Robert S. Benjamin
Publikováno v:
Cancer. 88:1703-1709
BACKGROUND The authors tested a biotherapy regimen involving recombinant interferon-α-2a (rIFN-α-2a) and recombinant human interleukin-2 (rhIL-2), given in a “decrescendo” schedule over 5 days, for its activity and toxicity in 21 patients who p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3aca7a229c15b5dbbb4a819b2e699aef
https://doi.org/10.1002/(sici)1097-0142(20000401)88:7<1703::aid-cncr26>3.0.co
https://doi.org/10.1002/(sici)1097-0142(20000401)88:7<1703::aid-cncr26>3.0.co
Publikováno v:
Melanoma Research. 9:575-582
In order to evaluate the natural history, prognostic parameters and treatment modalities for metastatic uveal melanoma, a review of the clinical data from the current literature was performed based on a Medline database search. Uveal melanoma represe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fda3d0a833c110fbd4a1786e55cc3a97
https://doi.org/10.1097/00008390-199912000-00006
https://doi.org/10.1097/00008390-199912000-00006
Autor:
S. S. Legha, Viallet J, Nicholas E. Papadopoulos, Carl Plager, Agop Y. Bedikian, Antonio C. Buzaid, Omar Eton, Susan McIntyre
Publikováno v:
Anti-Cancer Drugs. 10:735-740
A phase II study was undertaken to determine the efficacy of tirapazamine combined with cisplatin in patients with metastatic melanoma between April 1996 and April 1997. Tirapazamine 390 mg/m2, administered i.v. over 2 h, followed in 1 h by cisplatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aafa8ba16284d51e83ec24fc2fcdb51
https://doi.org/10.1097/00001813-199909000-00007
https://doi.org/10.1097/00001813-199909000-00007
Autor:
S. Coates, Omar Eton, R. von Roemeling, A. C. Buzaid, T. Simmons, N. Papadopoulos, A. Y. Bedikian, J. Neefe, S. S. Legha
Publikováno v:
Annals of Oncology. 8:363-367
Summary Purpose A phase II study was undertaken to determine the efficacy of tirapazamine (TPZ) combined with cisplatin (cDDP) in patients with metastatic melanoma. Patients and methods Between June 1994 and November 1995, 48 patients with metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a63db0f65634aef6d78ae5317f74c3f
https://doi.org/10.1023/a:1008249232000
https://doi.org/10.1023/a:1008249232000
Autor:
Howard A. Burris, J R Eckardt, J Jenkins, Geoffrey R. Weiss, S. S. Legha, Agop Y. Bedikian, Omar Eton, D. D. Von Hoff, L Smetzer, Antonio C. Buzaid
Publikováno v:
Journal of Clinical Oncology. 13:2895-2899
PURPOSE A phase II study was undertaken to determine the efficacy of docetaxel in patients with metastatic malignant melanoma. PATIENTS AND METHODS Between June 1992 and March 1994, 40 patients with metastatic malignant melanoma and no prior chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f028f98e45979bad1b697929b2cddcaf
https://doi.org/10.1200/jco.1995.13.12.2895
https://doi.org/10.1200/jco.1995.13.12.2895
Autor:
J. Jack Lee, Robert S. Benjamin, Charles M. Balch, S. S. Legha, Antonio C. Buzaid, Z N Tu, L A Tinoco, M. I. Ross, D Jendiroba
Publikováno v:
Journal of Clinical Oncology. 13:2361-2368
PURPOSE To determine the prognostic significance of the size of the lymph node mass as measured by physical examination (PE) and of the size of the largest node measured by pathologic analysis (path) in patients with cutaneous melanoma and nodal meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ceb0ca62a6aab7619c11ed5f4a960c7
https://doi.org/10.1200/jco.1995.13.9.2361
https://doi.org/10.1200/jco.1995.13.9.2361
Autor:
Alberto Fusi, Emilio Bajetta, Mario Roberto Sertoli, Barbara Formisano, Paola Taveggia, M. Del Vecchio, P. Nova, S. S. Legha, A. Daponte, Paola Queirolo, Natale Cascinelli, Maria Grazia Bernengo
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 17(4)
Background: The addition of cytokines to chemotherapy (CT) has obtained encouraging but contradictory results in metastatic melanoma. In this phase III trial, we compared the effects of CT [cisplatin, vindesine and dacarbazine (CVD)] with those of co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e8e6cccf6badd7b31f130acfb381be
https://pubmed.ncbi.nlm.nih.gov/16469753
https://pubmed.ncbi.nlm.nih.gov/16469753